SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+2.8%Nov 18 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Flagrante Delictu who wrote (17254)3/11/1998 5:36:00 PM
From: WTDEC  Read Replies (2) of 32384
 
Bernie, you have a wonderful command of the English and other more exotic languages, so I would like your review here. Here is what the press release said:

"Should Ligand elect to obtain
selected rights to the product, Lilly could receive milestones of up to $20
million in Ligand stock.ÿ In the event Ligand does not exercise this product
option, Ligand may elect to sell an additional $20 million in equity to Lilly
at a 20 percent premium to the then market price, and qualify for certain
additional royalties on net sales on Ligand's choice "

I read the words "to the then market price" to mean the stock is priced when the decision is made. You seem to have a different read. What do you think they meant?

Also, if LGND selects a drug and pays the royalties th LLY, do you think a the 20% premium applies?

Thanks,

Walter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext